BIOT Biotech Acquisition Company - Class A
Biotech Acquisition Company is a blank check company. The company was incorporated in 2020 and is based in New York, New York.
On 11/8/2021 the company announced a proposed merger with Blade Therapeutics, Inc. (“Blade”), a biopharmaceutical company based in South San Francisco, Calif.
$9.97 -0.00 (-0.05%)
As of 05/24/2022 15:59:07 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Micro cap
GICS sector: Financials
Industry: Shell Companies
Index country: USA
Country of incorporation: Sweden
IPO date: 03/18/2021
Outstanding shares: 23,000,000
Average volume: 256,740
Market cap: $228,965,000
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
Sedol: B1VN5T8
Valuation (See tab for details)
PE ratio: 0.00
PB ratio: 0.00
PS ratio: 0.00
Return on equity: 0.00%
Net income %: 0.00%